Connect with us

Healthcare Buzz

Caplin gets approval from Colombia drug regulator

Caplin Point Laboratories has received approval from Colombia’s drug regulatory body, The Colombia National Food and Drug Surveillance Institute (INVIMA), for its small-volume sterile injectable division at Puducherry. The inspection was carried out on May 10.

The Puducherry unit of Caplin Laboratories manufactures liquid injectables in vials, ampoules, lyophilized vials, and pre-filled syringes, amongst other dosage forms. It currently caters to Latin-American and African markets and manufactures various dosage forms such as tablets, capsules, liquid orals, and topicals. The site was found compliant to INVIMA’s norms of good manufacturing practices (GMP) and good laboratory practices (GLP). The company has received over 2800 product approvals.

Copyright © 2024 Medical Buyer

error: Content is protected !!